Cardiology

Should physicians critically reconsider their management strategy for ACS in a broad spectrum of patients with ACS

The MD Magazine editors rounded up the 10 best stories from December—did you read them all?

In a new study, stroke occurred in 6.6% of the ranibizumab-treated group, compared with 7.0% of the controls matched by sociodemographic factors and comorbidities and 6.7% of the controls matched by sociodemographic factors only. These differences were not statistically significant.

The US Food and Drug Administration approved dropping black box warning on two smoking cessation aids.

Maryland researchers found that even mild hypoglycemia can pose a cardiovascular risk in obese people with diabetes.

A retrospective analysis of nutrition studies showed magnesium can reduce heart failure and diabetes risk. The key is dosage, a team found.

Despite the fact that two thirds of stroke survivors could suffer from a visual impairment, nearly half of stroke units do not even assess vision. A recent report suggests that more must be done to assess the outlook for vision in stroke survivors.

The latest tallies on US life expectancy show its down a bit.

Empagliflozin was approved to reduce heart and stroke risk in patients with diabetes.

Several studies have shown that patients with sleep apnea are more likely than others to develop atrial fibrillation, but recent information indicates that any type of disrupted sleep may indicate an elevated risk.

At AHA 2016, Poushali Mukherjea, PhD, Bristol-Myers Squibb, discusses 12 abstracts on new real-world data and subanalyses from the pivotal trial ARISTOTLE.

It is reportedly safe to use tissue plasminogen activator, the clot busting medication, on patients who wake up with symptoms of stroke, according to a new study. Generally, tPA should be administered within 4.5 hours of symptom onset to be considered effective.

The first study using a national inpatient database finds PAH-related costs, comorbidities are increasing.

The MD Magazine editors rounded up the 10 best stories from November – did you read them all?

As the field of medical ethics continues to expand, its use can be seen in everything from general medical conditions to end of life considerations.

Following a stroke, the sooner a patient undergoes clot-busting endovascular thrombectomy, the better their outcomes are, in terms of severity of disability.

For men afflicted with type 2 diabetes and at high risk for heart attacks; however, relief might be found in an unlikely source – the erectile dysfunction drug Viagra (sildenafil).

By the time patients need a left ventricular assist device their condition has already worsened considerably. With the help of a combination of technology and medication there is some research to show that improvement is possible in many patients.

Pending further research a new powerful pharmaceutical combination could make a significant difference in the treatment of patients with a left ventricular assist device.

For patients who receive left ventricular assist device implants there is no assurance that the device will work enough for them to have a high quality of life. New research has shown a potential treatment which could make a significant improvement in this area.

Researchers in Denmark recently reported that hospital-diagnosed atopic dermatitis is associated with a greater risk of myocardial infarction.

As more men and women who served their country come home their skills can be put to good use in the medical community. Finding those veterans and reservists and getting them the training they need can make all the difference in their life out of uniform.

While medics and corpsmen in the military do similar jobs to what nurses do in civilian practice, those skills do not translate into certification when they leave the service.

When veterans, including medics and corpsmen come back from serving overseas their medical skills do not automatically translate into certification. Colleges and Universities are developing programs to help them and also reservists earn their bachelor of science in nursing degrees.

Analysis of data from a large survey has identified a number of factors that predict depression in women with diabetes and could help physicians provide better care for such patients.

Since they were first approved for patient care more than a year ago PCSK9 inhibitors have shown to be a powerful tool in the fight against dangerously high cholesterol levels. However, there are still challenges standing in the way of them being made more widely available.

The annual American Heart Association Scientific Sessions were filled with a wide range of presentations made in New Orleans. It was the late breaking news that made the most impact for those in attendance as they look to the future of cardiac care.

As the American Heart Association wrapped up another successful conference in New Orleans, each of the approximately 18,000 providers in attendance was bringing home something new to their practices or optimism for new treatments to come in the future.

Novel oral anticoagulants have made treatment of many patients considerably easier over the past few years. Finding ways to apply that to veterans can help a patient population deserving of high quality health care.